Muir, A. J., Taghipour, M., Hassanzadeh, E., Sahni, V. A., Sainani, N., Shiffman, M. L., … Tempany-Afdhal, C. (2017). Radiologic progression in primary sclerosing cholangitis (PSC) by two-dimensional magnetic resonance cholangiopancreatography (MRCP): Prospective data from a randomized controlled trial. In HEPATOLOGY (Vol. 66, pp. 156A-156A). Washington, DC: WILEY.

Muir, Andrew J., Mehdi Taghipour, Elmira Hassanzadeh, V Anik Sahni, Nisha Sainani, Mitchell L. Shiffman, Dora Ding, et al. “Radiologic progression in primary sclerosing cholangitis (PSC) by two-dimensional magnetic resonance cholangiopancreatography (MRCP): Prospective data from a randomized controlled trial.” In HEPATOLOGY, 66:156A-156A. WILEY, 2017.

Muir AJ, Taghipour M, Hassanzadeh E, Sahni VA, Sainani N, Shiffman ML, et al. Radiologic progression in primary sclerosing cholangitis (PSC) by two-dimensional magnetic resonance cholangiopancreatography (MRCP): Prospective data from a randomized controlled trial. In: HEPATOLOGY. WILEY; 2017. p. 156A-156A.

Muir, Andrew J., et al. “Radiologic progression in primary sclerosing cholangitis (PSC) by two-dimensional magnetic resonance cholangiopancreatography (MRCP): Prospective data from a randomized controlled trial.” HEPATOLOGY, vol. 66, WILEY, 2017, pp. 156A-156A.

Muir AJ, Taghipour M, Hassanzadeh E, Sahni VA, Sainani N, Shiffman ML, Ding D, Jia C, McColgan BJ, Myers RP, Subramanian M, McHutchison JG, Goodman ZD, Eksteen B, Manns MP, Levy C, Bowlus CL, Chapman RW, Tempany-Afdhal C. Radiologic progression in primary sclerosing cholangitis (PSC) by two-dimensional magnetic resonance cholangiopancreatography (MRCP): Prospective data from a randomized controlled trial. HEPATOLOGY. WILEY; 2017. p. 156A-156A.